{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:36:00Z","timestamp":1787502960027,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T00:00:00Z","timestamp":1587686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T00:00:00Z","timestamp":1587686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s12020-020-02302-8","type":"journal-article","created":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T13:03:34Z","timestamp":1587733414000},"page":"249-261","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Efficacy and safety of statin use in children and adolescents with familial hypercholesterolaemia: a systematic review and meta-analysis of randomized-controlled trials"],"prefix":"10.1007","volume":"69","author":[{"given":"Panagiotis","family":"Anagnostis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantina","family":"Vaitsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiota","family":"Kleitsioti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrysanthi","family":"Mantsiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Pavlogiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasilios G.","family":"Athyros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri P.","family":"Mikhailidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios G.","family":"Goulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,24]]},"reference":[{"issue":"36","key":"2302_CR1","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1093\/eurheartj\/ehv157","volume":"36","author":"A Wiegman","year":"2015","unstructured":"A. Wiegman, S.S. Gidding, G.F. Watts, M.J. Chapman, H.N. Ginsberg, M. Cuchel, L. Ose, M. Averna, C. Boileau, J. Boren, E. Bruckert, A.L. Catapano, J.C. Defesche, O.S. Descamps, R.A. Hegele, G.K. Hovingh, S.E. Humphries, P.T. Kovanen, J.A. Kuivenhoven, L. Masana, B.G. Nordestgaard, P. Pajukanta, K.G. Parhofer, F.J. Raal, K.K. Ray, R.D. Santos, A.F. Stalenhoef, E. Steinhagen-Thiessen, E.S. Stroes, M.R. Taskinen, A. Tybjaerg-Hansen, O. Wiklund, Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment. Eur. Heart J. 36(36), 2425\u20132437 (2015). https:\/\/doi.org\/10.1093\/eurheartj\/ehv157","journal-title":"Eur. Heart J."},{"issue":"31","key":"2302_CR2","doi-asserted-by":"publisher","first-page":"3665","DOI":"10.2174\/1381612824666181010150958","volume":"24","author":"P Anagnostis","year":"2018","unstructured":"P. Anagnostis, P. Siolos, D. Krikidis, D.G. Goulis, J.C. Stevenson, Should we consider lipoprotein (a) in cardiovascular disease Risk assessment in patients with familial hypercholesterolaemia? Cur. Pharm. Des. 24(31), 3665\u20133671 (2018). https:\/\/doi.org\/10.2174\/1381612824666181010150958","journal-title":"Cur. Pharm. Des."},{"issue":"45","key":"2302_CR3","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","volume":"34","author":"BG Nordestgaard","year":"2013","unstructured":"B.G. Nordestgaard, M.J. Chapman, S.E. Humphries, H.N. Ginsberg, L. Masana, O.S. Descamps, O. Wiklund, R.A. Hegele, F.J. Raal, J.C. Defesche, A. Wiegman, R.D. Santos, G.F. Watts, K.G. Parhofer, G.K. Hovingh, P.T. Kovanen, C. Boileau, M. Averna, J. Boren, E. Bruckert, A.L. Catapano, J.A. Kuivenhoven, P. Pajukanta, K. Ray, A.F. Stalenhoef, E. Stroes, M.R. Taskinen, A. Tybjaerg-Hansen, Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur. Heart J. 34(45), 3478\u20133490a (2013). https:\/\/doi.org\/10.1093\/eurheartj\/eht273","journal-title":"Eur. Heart J."},{"issue":"1","key":"2302_CR4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"F. Mach, C. Baigent, A.L. Catapano, K.C. Koskinas, M. Casula, L. Badimon, M.J. Chapman, G.G. De Backer, V. Delgado, B.A. Ference, I.M. Graham, A. Halliday, U. Landmesser, B. Mihaylova, T.R. Pedersen, G. Riccardi, D.J. Richter, M.S. Sabatine, M.R. Taskinen, L. Tokgozoglu, O. Wiklund; Group, E.S.C.S.D., 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur. Heart J. 41(1), 111\u2013188 (2020). https:\/\/doi.org\/10.1093\/eurheartj\/ehz455","journal-title":"Eur. Heart J."},{"issue":"2","key":"2302_CR5","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.atherosclerosis.2006.09.030","volume":"195","author":"C Arambepola","year":"2007","unstructured":"C. Arambepola, A.J. Farmer, R. Perera, H.A. Neil, Statin treatment for children and adolescents with heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis. Atherosclerosis 195(2), 339\u2013347 (2007). https:\/\/doi.org\/10.1016\/j.atherosclerosis.2006.09.030","journal-title":"Atherosclerosis"},{"issue":"4","key":"2302_CR6","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1007\/s00246-008-9364-3","volume":"30","author":"CS O\u2019Gorman","year":"2009","unstructured":"C.S. O\u2019Gorman, M.F. Higgins, M.B. O\u2019Neill, Systematic review and metaanalysis of statins for heterozygous familial hypercholesterolemia in children: evaluation of cholesterol changes and side effects. Pediatr. Cardiol. 30(4), 482\u2013489 (2009). https:\/\/doi.org\/10.1007\/s00246-008-9364-3","journal-title":"Pediatr. Cardiol."},{"issue":"6","key":"2302_CR7","doi-asserted-by":"publisher","first-page":"810","DOI":"10.5935\/abc.20180180","volume":"111","author":"G Radaelli","year":"2018","unstructured":"G. Radaelli, G. Sausen, C.C. Cesa, F.S. Santos, V.L. Portal, J.L. Neyeloff, L.C. Pellanda, Statin treatments and dosages in children with familial hypercholesterolemia: meta-analysis. Arq. Bras. Cardiol. 111(6), 810\u2013821 (2018). https:\/\/doi.org\/10.5935\/abc.20180180","journal-title":"Arq. Bras. Cardiol."},{"key":"2302_CR8","doi-asserted-by":"publisher","unstructured":"Vuorio, A., Kuoppala, J., Kovanen, P.T., Humphries, S.E., Tonstad, S., Wiegman, A., Drogari, E., Ramaswami, U.: Statins for children with familial hypercholesterolemia. Cochrane Database Syst. Rev. 2019(11) (2019). https:\/\/doi.org\/10.1002\/14651858.CD006401.pub5","DOI":"10.1002\/14651858.CD006401.pub5"},{"issue":"16","key":"2302_CR9","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1056\/NEJMoa1816454","volume":"381","author":"IK Luirink","year":"2019","unstructured":"I.K. Luirink, A. Wiegman, D.M. Kusters, M.H. Hof, J.W. Groothoff, E. de Groot, J.J.P. Kastelein, B.A. Hutten, 20-Year Follow-up of statins in children with familial hypercholesterolemia. N. Engl. J. Med. 381(16), 1547\u20131556 (2019). https:\/\/doi.org\/10.1056\/NEJMoa1816454","journal-title":"N. Engl. J. Med."},{"key":"2302_CR10","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"A. Liberati, D.G. Altman, J. Tetzlaff, C. Mulrow, P.C. Gotzsche, J.P. Ioannidis, M. Clarke, P.J. Devereaux, J. Kleijnen, D. Moher, The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339, b2700 (2009). https:\/\/doi.org\/10.1136\/bmj.b2700","journal-title":"BMJ"},{"key":"2302_CR11","unstructured":"Programme, W.H.O.H.G.: Familial hypercholesterolaemia (FH): report of a second WHO consultation, Geneva, 4 September 1998. In., vol. WHO\/HGN\/FH\/CONS\/99.2. World Health Organization, Geneva, (1999)"},{"issue":"6807","key":"2302_CR12","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1136\/bmj.303.6807.893","volume":"303","author":"Scientific Steering Committee on behalf of the Simon Broome Register Group","year":"1991","unstructured":"Scientific Steering Committee on behalf of the Simon Broome Register Group, Risk of fatal coronary heart disease in familial hypercholesterolaemia. BMJ 303(6807), 893\u2013896 (1991). https:\/\/doi.org\/10.1136\/bmj.303.6807.893","journal-title":"BMJ"},{"issue":"2","key":"2302_CR13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0002-9149(93)90155-6","volume":"72","author":"RR Williams","year":"1993","unstructured":"R.R. Williams, S.C. Hunt, M.C. Schumacher, R.A. Hegele, M.F. Leppert, E.H. Ludwig, P.N. Hopkins, Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics. Am. J. Cardiol. 72(2), 171\u2013176 (1993). https:\/\/doi.org\/10.1016\/0002-9149(93)90155-6","journal-title":"Am. J. Cardiol."},{"key":"2302_CR14","doi-asserted-by":"publisher","unstructured":"Representatives of the Global Familial Hypercholesterolemia, C. Wilemon, K.A. Patel, J. Aguilar-Salinas, C. Ahmed, C.D. Alkhnifsawi, M. Almahmeed, W. Alonso, R. Al-Rasadi, K. Badimon, L. Bernal, L.M. Bogsrud, M.P. Braun, L.T. Brunham, L. Catapano, A.L. Cill\u00edkov\u00e1, K. Corral, P. Cuevas, R. Defesche, J.C. Descamps, O.S. de Ferranti, S. Eisel\u00e9, J.-L. Elikir, G. Folco, E. Freiberger, T. Fuggetta, F. Gaspar, I.M. Gesztes, \u00c1.G. Gro\u0161elj, U. Hamilton-Craig, I. Hanauer-Mader, G. Harada-Shiba, M. Hastings, G. Hovingh, G.K. Izar, M.C. Jamison, A. Karlsson, G.N. Kayik\u00e7ioglu, M. Koob, S. Koseki, M. Lane, S. Lima-Martinez, M.M. L\u00f3pez, G. Martinez, T.L. Marais, D. Marion, L. Mata, P. Maurina, I. Maxwell, D. Mehta, R. Mensah, G.A. Miserez, A.R. Neely, D. Nicholls, S.J. Nohara, A. Nordestgaard, B.G. Ose, L. Pallidis, A. Pang, J. Payne, J. Peterson, A.L. Popescu, M.P. Puri, R. Ray, K.K. Reda, A. Sampietro, T. Santos, R.D. Schalkers, I. Schreier, L. Shapiro, M.D. Sijbrands, E. Soffer, D. Stefanutti, C. Stoll, M. Sy, R.G. Tamayo, M.L. Tilney, M.K. Tokg\u00f6zoglu, L. Tomlinson, B. Vallejo-Vaz, A.J. Vazquez-C\u00e1rdenas, A. de Luca, P.V. Wald, D.S. Watts, G.F. Wenger, N.K. Wolf, M. Wood, D. Zegerius, A. Gaziano, T.A. Gidding, S.S.: Reducing the clinical and public health burden of familial hypercholesterolemia: a global call to action. JAMA Cardiol. https:\/\/doi.org\/10.1001\/jamacardio.2019.5173 (2020)","DOI":"10.1001\/jamacardio.2019.5173"},{"key":"2302_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"X. Wan, W. Wang, J. Liu, T. Tong, Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med. Res. Methodol. 14, 135 (2014). https:\/\/doi.org\/10.1186\/1471-2288-14-135","journal-title":"BMC Med. Res. Methodol."},{"issue":"5","key":"2302_CR16","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1203\/00006450-199605000-00021","volume":"39","author":"HC Knipscheer","year":"1996","unstructured":"H.C. Knipscheer, C.C. Boelen, J.J. Kastelein, D.E. van Diermen, B.E. Groenemeijer, A. van den Ende, H.R. Buller, H.D. Bakker, Short-term efficacy and safety of pravastatin in 72 children with familial hypercholesterolemia. Pediatr. Res. 39(5), 867\u2013871 (1996). https:\/\/doi.org\/10.1203\/00006450-199605000-00021","journal-title":"Pediatr. Res."},{"issue":"6","key":"2302_CR17","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1161\/01.ATV.18.6.1007","volume":"18","author":"P Couture","year":"1998","unstructured":"P. Couture, L.D. Brun, F. Szots, M. Lelievre, D. Gaudet, J.P. Despres, J. Simard, P.J. Lupien, C. Gagne, Association of specific LDL receptor gene mutations with differential plasma lipoprotein response to simvastatin in young French Canadians with heterozygous familial hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 18(6), 1007\u20131012 (1998)","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"2302_CR18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1001\/jama.281.2.137","volume":"281","author":"EA Stein","year":"1999","unstructured":"E.A. Stein, D.R. Illingworth, P.O. Kwiterovich Jr., C.A. Liacouras, M.A. Siimes, M.S. Jacobson, T.G. Brewster, P. Hopkins, M. Davidson, K. Graham, F. Arensman, R.H. Knopp, C. DuJovne, C.L. Williams, J.L. Isaacsohn, C.A. Jacobsen, P.M. Laskarzewski, S. Ames, G.J. Gormley, Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial. JAMA 281(2), 137\u2013144 (1999). https:\/\/doi.org\/10.1001\/jama.281.2.137","journal-title":"JAMA"},{"issue":"17","key":"2302_CR19","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1161\/01.cir.0000035247.42888.82","volume":"106","author":"S de Jongh","year":"2002","unstructured":"S. de Jongh, L. Ose, T. Szamosi, C. Gagne, M. Lambert, R. Scott, P. Perron, D. Dobbelaere, M. Saborio, M.B. Tuohy, M. Stepanavage, A. Sapre, B. Gumbiner, M. Mercuri, A.S. van Trotsenburg, H.D. Bakker, J.J. Kastelein, Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, double-blind, placebo-controlled trial with simvastatin. Circulation 106(17), 2231\u20132237 (2002). https:\/\/doi.org\/10.1161\/01.cir.0000035247.42888.82","journal-title":"Circulation"},{"issue":"1","key":"2302_CR20","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/s0022-3476(03)00186-0","volume":"143","author":"BW McCrindle","year":"2003","unstructured":"B.W. McCrindle, L. Ose, A.D. Marais, Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial. J. Pediatr. 143(1), 74\u201380 (2003). https:\/\/doi.org\/10.1016\/s0022-3476(03)00186-0","journal-title":"J. Pediatr."},{"issue":"3","key":"2302_CR21","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1001\/jama.292.3.331","volume":"292","author":"A Wiegman","year":"2004","unstructured":"A. Wiegman, B.A. Hutten, E. de Groot, J. Rodenburg, H.D. Bakker, H.R. Buller, E.J. Sijbrands, J.J. Kastelein, Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial. JAMA 292(3), 331\u2013337 (2004). https:\/\/doi.org\/10.1001\/jama.292.3.331","journal-title":"JAMA"},{"issue":"3","key":"2302_CR22","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1542\/peds.2004-2090","volume":"116","author":"SB Clauss","year":"2005","unstructured":"S.B. Clauss, K.W. Holmes, P. Hopkins, E. Stein, M. Cho, A. Tate, A.O. Johnson-Levonas, P.O. Kwiterovich, Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia. Pediatrics 116(3), 682\u2013688 (2005). https:\/\/doi.org\/10.1542\/peds.2004-2090","journal-title":"Pediatrics"},{"issue":"11","key":"2302_CR23","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.jacc.2009.10.042","volume":"55","author":"HJ Avis","year":"2010","unstructured":"H.J. Avis, B.A. Hutten, C. Gagne, G. Langslet, B.W. McCrindle, A. Wiegman, J. Hsia, J.J. Kastelein, E.A. Stein, Efficacy and safety of rosuvastatin therapy for children with familial hypercholesterolemia. J. Am. Coll. Cardiol. 55(11), 1121\u20131126 (2010). https:\/\/doi.org\/10.1016\/j.jacc.2009.10.042","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"2302_CR24","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jpeds.2015.05.006","volume":"167","author":"MJ Braamskamp","year":"2015","unstructured":"M.J. Braamskamp, C. Stefanutti, G. Langslet, E. Drogari, A. Wiegman, N. Hounslow, J.J. Kastelein, Efficacy and safety of pitavastatin in children and adolescents at high future cardiovascular risk. J. Pediatr. 167(2), 338\u2013343.e335 (2015). https:\/\/doi.org\/10.1016\/j.jpeds.2015.05.006","journal-title":"J. Pediatr."},{"issue":"1","key":"2302_CR25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5551\/jat.28753","volume":"23","author":"M Harada-Shiba","year":"2016","unstructured":"M. Harada-Shiba, O. Arisaka, A. Ohtake, T. Okada, H. Suganami, Efficacy and safety of pitavastatin in Japanese male children with familial hypercholesterolemia. J. Atheroscler. Thromb. 23(1), 48\u201355 (2016). https:\/\/doi.org\/10.5551\/jat.28753. Epub 20 Apr 2015","journal-title":"J. Atheroscler. Thromb."},{"key":"2302_CR26","doi-asserted-by":"publisher","first-page":"g3743","DOI":"10.1136\/bmj.g3743","volume":"349","author":"CS Desai","year":"2014","unstructured":"C.S. Desai, S.S. Martin, R.S. Blumenthal, Non-cardiovascular effects associated with statins. BMJ 349, g3743 (2014). https:\/\/doi.org\/10.1136\/bmj.g3743","journal-title":"BMJ"},{"issue":"9756","key":"2302_CR27","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1016\/s0140-6736(10)61272-x","volume":"376","author":"VG Athyros","year":"2010","unstructured":"V.G. Athyros, K. Tziomalos, T.D. Gossios, T. Griva, P. Anagnostis, K. Kargiotis, E.D. Pagourelias, E. Theocharidou, A. Karagiannis, D.P. Mikhailidis, Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis. Lancet 376(9756), 1916\u20131922 (2010). https:\/\/doi.org\/10.1016\/s0140-6736(10)61272-x","journal-title":"Lancet"},{"issue":"25","key":"2302_CR28","doi-asserted-by":"publisher","first-page":"7860","DOI":"10.3748\/wjg.v21.i25.7860","volume":"21","author":"K Kargiotis","year":"2015","unstructured":"K. Kargiotis, V.G. Athyros, O. Giouleme, N. Katsiki, E. Katsiki, P. Anagnostis, C. Boutari, M. Doumas, A. Karagiannis, D.P. Mikhailidis, Resolution of non-alcoholic steatohepatitis by rosuvastatin monotherapy in patients with metabolic syndrome. World J. Gastroenterol. 21(25), 7860\u20137868 (2015). https:\/\/doi.org\/10.3748\/wjg.v21.i25.7860","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"2302_CR29","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s42000-019-00107-7","volume":"18","author":"F Tzifi","year":"2019","unstructured":"F. Tzifi, A. Fretzayas, G. Chrousos, C. Kanaka-Gantenbein, Non-alcoholic fatty liver infiltration in children: an underdiagnosed evolving disease. Hormones 18(3), 255\u2013265 (2019). https:\/\/doi.org\/10.1007\/s42000-019-00107-7","journal-title":"Hormones"},{"issue":"9716","key":"2302_CR30","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","volume":"375","author":"N Sattar","year":"2010","unstructured":"N. Sattar, D. Preiss, H.M. Murray, P. Welsh, B.M. Buckley, A.J. de Craen, S.R. Seshasai, J.J. McMurray, D.J. Freeman, J.W. Jukema, P.W. Macfarlane, C.J. Packard, D.J. Stott, R.G. Westendorp, J. Shepherd, B.R. Davis, S.L. Pressel, R. Marchioli, R.M. Marfisi, A.P. Maggioni, L. Tavazzi, G. Tognoni, J. Kjekshus, T.R. Pedersen, T.J. Cook, A.M. Gotto, M.B. Clearfield, J.R. Downs, H. Nakamura, Y. Ohashi, K. Mizuno, K.K. Ray, I. Ford, Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet 375(9716), 735\u2013742 (2010). https:\/\/doi.org\/10.1016\/S0140-6736(09)61965-6","journal-title":"Lancet"},{"issue":"6","key":"2302_CR31","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/j.1742-1241.2011.02655.x","volume":"65","author":"P Anagnostis","year":"2011","unstructured":"P. Anagnostis, D. Selalmatzidou, S.A. Polyzos, A. Panagiotou, A. Slavakis, A. Panagiotidou, V.G. Athyros, A. Karagiannis, D.P. Mikhailidis, M. Kita, Comparative effects of rosuvastatin and atorvastatin on glucose metabolism and adipokine levels in non-diabetic patients with dyslipidaemia: a prospective randomised open-label study. Int. J. Clin. Pract. 65(6), 679\u2013683 (2011). https:\/\/doi.org\/10.1111\/j.1742-1241.2011.02655.x","journal-title":"Int. J. Clin. Pract."},{"issue":"5","key":"2302_CR32","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1089\/met.2012.0063","volume":"10","author":"V Panz","year":"2012","unstructured":"V. Panz, A. Immelman, J. Paiker, G. Pilcher, F. Raal, High-dose statin therapy does not induce insulin resistance in patients with familial hypercholesterolemia. Metab. Syndr. Relat. Disord. 10(5), 351\u2013357 (2012). https:\/\/doi.org\/10.1089\/met.2012.0063","journal-title":"Metab. Syndr. Relat. Disord."},{"issue":"1","key":"2302_CR33","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.atherosclerosis.2014.08.047","volume":"237","author":"J Skoumas","year":"2014","unstructured":"J. Skoumas, C. Liontou, C. Chrysohoou, C. Masoura, K. Aznaouridis, C. Pitsavos, C. Stefanadis, Statin therapy and risk of diabetes in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia. Atherosclerosis 237(1), 140\u2013145 (2014). https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.08.047","journal-title":"Atherosclerosis"},{"issue":"1","key":"2302_CR34","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/s0021-9150(02)00005-9","volume":"163","author":"VG Athyros","year":"2002","unstructured":"V.G. Athyros, A.A. Papageorgiou, A.G. Kontopoulos, Long-term treatment with atorvastatin in adolescent males with heterozygous familial hypercholesterolemia. Atherosclerosis 163(1), 205\u2013206 (2002). https:\/\/doi.org\/10.1016\/s0021-9150(02)00005-9","journal-title":"Atherosclerosis"},{"issue":"2","key":"2302_CR35","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.atherosclerosis.2015.05.034","volume":"241","author":"MJ Braamskamp","year":"2015","unstructured":"M.J. Braamskamp, D.M. Kusters, A. Wiegman, H.J. Avis, F.A. Wijburg, J.J. Kastelein, A.S. van Trotsenburg, B.A. Hutten, Gonadal steroids, gonadotropins and DHEAS in young adults with familial hypercholesterolemia who had initiated statin therapy in childhood. Atherosclerosis 241(2), 427\u2013432 (2015). https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.05.034","journal-title":"Atherosclerosis"},{"issue":"10","key":"2302_CR36","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1001\/jama.2014.8892","volume":"312","author":"DM Kusters","year":"2014","unstructured":"D.M. Kusters, H.J. Avis, E. de Groot, F.A. Wijburg, J.J. Kastelein, A. Wiegman, B.A. Hutten, Ten-year follow-up after initiation of statin therapy in children with familial hypercholesterolemia. JAMA 312(10), 1055\u20131057 (2014). https:\/\/doi.org\/10.1001\/jama.2014.8892","journal-title":"JAMA"},{"issue":"9406","key":"2302_CR37","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/s0140-6736(04)15467-6","volume":"363","author":"A Wiegman","year":"2004","unstructured":"A. Wiegman, E. de Groot, B.A. Hutten, J. Rodenburg, J. Gort, H.D. Bakker, E.J. Sijbrands, J.J. Kastelein, Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia. Lancet 363(9406), 369\u2013370 (2004). https:\/\/doi.org\/10.1016\/s0140-6736(04)15467-6","journal-title":"Lancet"},{"issue":"2","key":"2302_CR38","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1161\/circresaha.114.301430","volume":"114","author":"DM Kusters","year":"2014","unstructured":"D.M. Kusters, A. Wiegman, J.J. Kastelein, B.A. Hutten, Carotid intima-media thickness in children with familial hypercholesterolemia. Circ. Res. 114(2), 307\u2013310 (2014). https:\/\/doi.org\/10.1161\/circresaha.114.301430","journal-title":"Circ. Res."},{"issue":"4","key":"2302_CR39","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1161\/CIRCULATIONAHA.116.025158","volume":"136","author":"M Braamskamp","year":"2017","unstructured":"M. Braamskamp, G. Langslet, B.W. McCrindle, D. Cassiman, G.A. Francis, C. Gagne, D. Gaudet, K.M. Morrison, A. Wiegman, T. Turner, E. Miller, D.M. Kusters, J.S. Raichlen, P.D. Martin, E.A. Stein, J.J.P. Kastelein, B.A. Hutten, Effect of rosuvastatin on carotid intima-media thickness in children with heterozygous familial hypercholesterolemia: the CHARON study (hypercholesterolemia in children and adolescents taking rosuvastatin open label). Circulation 136(4), 359\u2013366 (2017). https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.025158","journal-title":"Circulation"},{"issue":"17","key":"2302_CR40","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.jacc.2008.09.002","volume":"52","author":"A van der Graaf","year":"2008","unstructured":"A. van der Graaf, C. Cuffie-Jackson, M.N. Vissers, M.D. Trip, C. Gagne, G. Shi, E. Veltri, H.J. Avis, J.J. Kastelein, Efficacy and safety of coadministration of ezetimibe and simvastatin in adolescents with heterozygous familial hypercholesterolemia. J. Am. Coll. Cardiol. 52(17), 1421\u20131429 (2008). https:\/\/doi.org\/10.1016\/j.jacc.2008.09.002","journal-title":"J. Am. Coll. Cardiol."},{"issue":"9","key":"2302_CR41","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1016\/j.jacc.2005.12.047","volume":"47","author":"J Rodenburg","year":"2006","unstructured":"J. Rodenburg, M.N. Vissers, A. Wiegman, E.R. Miller, P.M. Ridker, J.L. Witztum, J.J. Kastelein, S. Tsimikas, Oxidized low-density lipoprotein in children with familial hypercholesterolemia and unaffected siblings: effect of pravastatin. J. Am. Coll. Cardiol. 47(9), 1803\u20131810 (2006). https:\/\/doi.org\/10.1016\/j.jacc.2005.12.047","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02302-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-020-02302-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-020-02302-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,25]],"date-time":"2021-04-25T01:03:23Z","timestamp":1619312603000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-020-02302-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,24]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["2302"],"URL":"https:\/\/doi.org\/10.1007\/s12020-020-02302-8","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,24]]},"assertion":[{"value":"11 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"D.P.M. has given talks and attended conferences sponsored by Amgen, AstraZeneca and Libytec. The other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}